Matt Kaeberlein
Matt Kaeberlein is a professor at the University of Washington and a co-founder of the Dog Aging Project, the largest study of canine health and aging ever undertaken. His research focuses on understanding how genetics, lifestyle, and environmental factors influence the longevity and health of dogs, with the aim of extending their lifespan and improving their quality of life. Kaeberlein is also involved in clinical trials testing the potential anti-aging drug rapamycin on dogs, seeking to discover ways to slow down the aging process in pets.
Born on Jan 01, 1970 (55 years old)
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Matt Kaeberlein is an expert in healthy aging who collaborated on the Dog Aging Project.
8
Liechtenstein:
Matt Kaeberlein commented on the importance of rigorous testing for lithium treatments for Alzheimer's.
7
Switzerland:
Matt Kaeberlein is a longevity researcher who conducted a self-experiment with Rapamycin.
8
Australia:
Matt Kaeberlein is an American biologist who criticized Sinclair's claims about anti-ageing supplements.
4
Australia:
Matt Kaeberlein is the co-founder of the Dog Aging Project and explains the components of the study.
7